UB Paderborn / Katalog / Suche / in CDI

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

Basic & clinical pharmacology & toxicology, 2019-04, Vol.124 (4), p.479-490

2019

Volltextzugriff (PDF)

Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV‐infected Patients: Efficacy, Safety and Tolerance

Basic & clinical pharmacology & toxicology, 2017-11, Vol.121 (5), p.442-446

2017

Volltextzugriff (PDF)

Effectiveness and safety of direct‐acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice

Journal of medical virology, 2020-12, Vol.92 (12), p.3488-3498

2020

Volltextzugriff (PDF)

Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: Clinical, Economic, and Patient-Perceived Quality Analysis

Telemedicine journal and e-health, 2019-05, Vol.25 (5), p.399

2019

Volltextzugriff (PDF)

Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis

Frontiers in medicine, 2022-12, Vol.9, p.1017323-1017323

2022

Volltextzugriff (PDF)

Observational Study to Compare Biological Drug Concentration Quantification Techniques and Immunogenicity in Patients with Immune-Mediated Diseases

Biomedicines, 2024-04, Vol.12 (4), p.839

2024

Volltextzugriff (PDF)

Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases

Journal of clinical pharmacy and therapeutics, 2021-08, Vol.46 (4), p.918-926

2021

Volltextzugriff (PDF)

Analysing Early Diagnosis Strategies for HIV Infection: A Retrospective Study of Missed Diagnostic Opportunities

Healthcare (Basel), 2024-01, Vol.12 (3), p.361

2024

Volltextzugriff (PDF)

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines

Journal of the International Association of Providers of AIDS Care, 2019-01, Vol.18, p.2325958218821940-2325958218821940

2019

Volltextzugriff (PDF)

Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors

AIDS (London), 2018-01, Vol.32 (1), p.121-125

2018

Volltextzugriff (PDF)

Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward

Farmacia hospitalaria, 2023-05, Vol.47 (3), p.121-126

2023

Volltextzugriff (PDF)

Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

Epilepsy & behavior, 2023-08, Vol.145, p.109350-109350, Article 109350

2023

Volltextzugriff (PDF)

Management of Everolimus and Voriconazole Interaction in Lung Transplant Patients

Therapeutic drug monitoring, 2016-06, Vol.38 (3), p.305

2016

Volltextzugriff (PDF)

Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week

Revista española de enfermedades digestivas, 2022-12, Vol.114 (12), p.708-712

2022

Volltextzugriff (PDF)

Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting

Revista española de quimioterapia, 2021-06, Vol.34 (3), p.200-206

2021

Volltextzugriff (PDF)

Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection

European journal of hospital pharmacy. Science and practice, 2023-05, Vol.30 (3), p.177-179

2023

Volltextzugriff (PDF)

Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study

European journal of hospital pharmacy. Science and practice, 2022-07, Vol.29 (4), p.207-211

2022

Volltextzugriff (PDF)

Lipid profile changes associated with antiretroviral therapies in a real-world cohort

Farmacia hospitalaria, 2023-09, Vol.47 (5), p.210-217

2023

Volltextzugriff (PDF)

Lipid profile changes associated with antiretroviral therapies in a real-world cohort

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2023-09, Vol.47 (5), p.210

2023

Volltextzugriff (PDF)

Fingolimod in multiple sclerosis: profile of use in habitual practice

European journal of hospital pharmacy. Science and practice, 2020-11, Vol.27 (6), p.346-349

2020

Volltextzugriff (PDF)

Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2021-12, Vol.45 (7), p.11

2021

Volltextzugriff (PDF)

Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

Dermatology and therapy, 2022-03, Vol.12 (3), p.761-770

2022

Volltextzugriff (PDF)

A complexity scale for clinical trials from the perspective of a pharmacy service

European journal of hospital pharmacy. Science and practice, 2018-09, Vol.25 (5), p.251-256

2018

Volltextzugriff (PDF)

Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

European journal of hospital pharmacy. Science and practice, 2023-07, Vol.30 (4), p.221-226

2023

Volltextzugriff (PDF)

e-Interconsultations between a hospital pharmacy service and primary care pharmacy units in Spain

European journal of hospital pharmacy. Science and practice, 2021-07, Vol.28 (4), p.202-206

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV‐infected Patients: Efficacy, Safety and Tolerance

Effectiveness and safety of direct‐acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice

Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: Clinical, Economic, and Patient-Perceived Quality Analysis

Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis

Observational Study to Compare Biological Drug Concentration Quantification Techniques and Immunogenicity in Patients with Immune-Mediated Diseases

Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases

Analysing Early Diagnosis Strategies for HIV Infection: A Retrospective Study of Missed Diagnostic Opportunities

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines

Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors

Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward

Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

Management of Everolimus and Voriconazole Interaction in Lung Transplant Patients

Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week

Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting

Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection

Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study

Lipid profile changes associated with antiretroviral therapies in a real-world cohort

Lipid profile changes associated with antiretroviral therapies in a real-world cohort

Fingolimod in multiple sclerosis: profile of use in habitual practice

Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches

Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

A complexity scale for clinical trials from the perspective of a pharmacy service

Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

e-Interconsultations between a hospital pharmacy service and primary care pharmacy units in Spain

Suchergebnisse filtern